marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2023-Q3
added 11-02-2023
ImmunoGen Financial Ratios 2011-2024 | IMGN
Annual Financial Ratios ImmunoGen
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.6 | -8.4 | -28.3 | -6.9 | -4.2 | -8.5 | -1.7 | -25.4 | -13.3 | -21.8 | -16.4 | -16.0 |
P/S |
9.3 | 16.7 | 9.5 | 8.8 | 13.4 | 7.1 | 4.0 | 18.0 | 15.9 | 44.8 | 73.7 | 48.3 |
EPS |
-0.9 | -0.7 | -0.2 | -0.7 | -1.2 | -1.0 | -1.8 | -0.7 | -0.8 | -0.9 | -0.9 | -0.8 |
EV (Enterprise Value) |
935 M | 886 M | 1.23 B | 857 M | 736 M | 861 M | 451 M | 1.57 B | 897 M | 1.49 B | 1.14 B | 819 M |
EBITDA per Share |
-0.86 | -0.6 | -0.12 | -0.45 | -1.07 | -0.533 | -1.38 | -0.569 | -0.783 | -0.813 | -0.893 | -0.802 |
EV/EBITDA |
-6.1 | -40.7 | -8.2 | -3.0 | -10.5 | -0.8 | -25.8 | -12.1 | -20.4 | -15.2 | -13.4 | |
PEG |
-0.06 | -0.14 | -2.79 | 0.17 | -0.19 | -1.04 | -0.01 | 1.75 | 2.89 | 2.59 | -1.4 | 6.96 |
P/B |
6.5 | 3.6 | 14.0 | -9.5 | 65.0 | -45.6 | -2.9 | 43.9 | 12.5 | 13.1 | 14.4 | 6.7 |
P/CF |
-4.4 | -6.9 | -16.0 | -7.9 | -4.2 | 125.0 | -1.8 | -24.6 | -15.4 | -24.8 | -32.4 | -93.1 |
ROE % |
-143.06 | -42.79 | -49.54 | 136.80 | -1538.85 | 536.53 | 175.95 | -173.03 | -94.27 | -59.76 | -87.40 | -41.63 |
ROA % |
-63.89 | -26.50 | -12.50 | -44.26 | -57.16 | -32.58 | -50.44 | -19.35 | -43.17 | -34.09 | -40.66 | -26.78 |
ROCE % |
-141.76 | -38.41 | -24.99 | -44.81 | -70.20 | -24.36 | -55.39 | -19.59 | -49.65 | -37.55 | -44.65 | -29.64 |
Current Ratio |
1.8 | 2.6 | 1.3 | 2.7 | 3.9 | 5.0 | 4.1 | 8.2 | 7.1 | 10.5 | 10.2 | 13.8 |
DSO |
- | - | - | 120.9 | 82.4 | 16.5 | 13.9 | 24.8 | 19.7 | 21.8 | 29.6 | 88.3 |
DIO |
- | - | - | - | - | 2.7 | 2.2 | 9.6 | 10.1 | 2.9 | - | - |
DPO |
- | - | - | 31.7 | 23.8 | 22.4 | 28.4 | 26.6 | 16.4 | 18.9 | - | - |
Operating Cycle |
- | - | - | 120.9 | 82.4 | 19.2 | 16.2 | 34.3 | 29.7 | 24.7 | - | - |
Cash Conversion Cycle |
- | - | - | 89.2 | 58.6 | -3.1 | -12.2 | 7.8 | 13.3 | 5.9 | - | - |
All numbers in USD currency
Quarterly Financial Ratios ImmunoGen
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.1 | -0.02 | -0.16 | - | -0.31 | -0.24 | -0.1 | - | -0.18 | -0.15 | -0.17 | - | -0.13 | -0.14 | -0.17 | 0.03 | -0.15 | -0.29 | -0.3 | -0.28 | -0.32 | -0.31 | -0.3 | -0.11 | -0.61 | -0.1 | -0.2 | -0.39 | -0.51 | -0.53 | -0.51 | -0.38 | -0.39 | -0.38 | -0.39 | 0.16 | -0.26 | 0.16 | -0.26 | 0.04 | -0.13 | 0.04 | -0.13 | -0.29 | -0.3 | -0.29 | -0.3 | -0.17 | -0.26 | -0.17 | -0.26 |
EBITDA per Share |
- | - | -0.16 | - | -0.3 | -0.24 | -0.09 | - | -0.16 | -0.14 | -0.14 | - | -0.09 | -0.1 | -0.14 | 0.06 | -0.1 | -0.26 | -0.27 | -0.27 | -0.27 | -0.25 | -0.26 | -0.07 | -0.29 | -0.03 | -0.13 | -0.33 | -0.43 | -0.43 | -0.43 | -0.32 | -0.32 | -0.3 | -0.32 | 0.16 | -0.24 | 0.19 | -0.24 | 0.04 | -0.12 | 0.07 | -0.12 | -0.29 | -0.29 | -0.26 | -0.31 | -0.17 | -0.24 | -0.14 | -0.27 |
ROE % |
-66.90 | -116.05 | -140.01 | -114.25 | -87.80 | -92.55 | -112.63 | -140.93 | -94.47 | -71.01 | 8.93 | 80.15 | 38.78 | 92.33 | 50.97 | 9.60 | -365.04 | -774.57 | -1149.21 | -1523.84 | -1069.58 | -152.09 | 278.42 | 756.31 | 705.35 | 198.08 | 178.58 | 120.44 | 297.23 | -22.67 | -139.52 | -239.90 | -421.43 | -168.58 | -63.75 | -31.61 | -46.28 | -17.89 | -32.77 | -12.55 | -33.42 | -40.03 | -72.24 | -93.06 | -86.18 | -85.90 | -65.94 | -49.83 | -15.74 | -9.11 | -13.92 |
ROA % |
-27.99 | -53.40 | -57.82 | -48.61 | -38.77 | -24.66 | -34.86 | -39.69 | -23.78 | -17.50 | 1.54 | 20.22 | 13.42 | 10.48 | 3.69 | -3.11 | -19.30 | -24.21 | -40.41 | -56.60 | -46.90 | -65.34 | -54.19 | -45.93 | -58.65 | -48.56 | -68.65 | -74.19 | -70.23 | -59.55 | -46.34 | -41.80 | -17.98 | -21.74 | -3.60 | -10.19 | -18.92 | -8.96 | -15.42 | -7.20 | -19.65 | -24.01 | -39.32 | -48.04 | -43.60 | -43.41 | -35.74 | -30.72 | -9.79 | -5.86 | -8.95 |
ROCE % |
-74.50 | -122.62 | -146.20 | -75.39 | -119.80 | -120.71 | -136.24 | -115.10 | -133.78 | -108.05 | -88.57 | -65.76 | -76.92 | -34.64 | 39.79 | 121.09 | -236.17 | -674.75 | -1081.88 | -1471.46 | -1048.08 | -459.21 | -77.32 | 329.60 | 293.38 | 144.90 | 142.73 | 117.86 | 268.27 | -3.59 | -110.51 | -239.20 | -390.56 | -181.27 | -82.66 | -30.10 | -45.01 | -17.35 | -32.47 | -12.83 | -33.74 | -40.30 | -72.59 | -93.38 | -86.44 | -86.11 | -66.03 | -49.84 | -15.73 | -9.13 | -13.91 |
Current Ratio |
3.2 | 3.2 | 1.7 | 1.8 | 2.0 | - | 2.8 | 2.6 | 1.4 | 1.3 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 0.8 | 0.8 | 0.8 | 0.8 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 0.6 | 0.6 | 0.6 | 0.8 | 0.9 | 1.0 | 1.1 | 1.1 | 2.5 | 1.7 | 1.8 | 1.8 | 2.8 | 2.5 | 2.3 | 2.3 | 2.4 | 2.6 | 1.9 | 1.9 | 2.2 | 2.6 | 2.8 | 2.8 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency